Ross Dixon

Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.

Michael Newman, Jennifer C. Rodarte, Khalid Benbatoul et al. · PubMed · 2000 · 191 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Investigation into the use of narcotic antagonists in the treatment of a stereotypic behavior pattern (crib-biting) in the horse

Nicholas H. Dodman, Louis Shuster, Michael H. Court et al. · American Journal of Veterinary Research · 1987 · 121 citations

Medicine, Pharmacology, Veterinary Pharmacology +14

AICA‐Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine‐Regulating Agent

Ross Dixon, James T. Gourzis, Daniel McDermott et al. · The Journal of Clinical Pharmacology · 1991 · 105 citations

Medicine, Pharmacokinetics, Pharmacology +13

Nalmefene: Intravenous safety and kinetics of a new opioid antagonist

Ross Dixon, John F. Howes, Joseph Gentile et al. · Clinical Pharmacology & Therapeutics · 1986 · 98 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist

Ross Dixon, Joseph Gentile, Hon‐Bin Hsu et al. · The Journal of Clinical Pharmacology · 1987 · 75 citations

Medicine, Pharmacokinetics, Pharmacology +14